To investigate how HDCA suppresses CRC growth, we examined its impact on FXR and TGR5 receptors, ultimately determining that HDCA curbs CRC proliferation via FXR activation, not TGR5. This evidence concerns the gene GPBAR1 and colorectal carcinoma.